A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
National Bleeding Disorders Foundation (NBDF) recently posted on X:
”A new review traces 200+ years of history on women and hemophilia, outlining nine eras of changing beliefs and testing practices.”
Learn the full article here.
Though the history of hemophilia is well recorded, it has long emphasized the male experience and severe disease forms.
A new narrative review by Megan Chaigneau et al. traces the evolution of beliefs about women and hemophilia from the pre-1800s to today, identifying 9 key historical periods where scientific shifts occurred.
The review underscores the dismissal of women’s bleeding symptoms throughout history, with 1990 marking a pivotal point of broader recognition that women can also be affected.
Despite progress in understanding and testing, recent literature reveals ongoing challenges including delayed diagnoses and untreated symptoms.
Though ‘The history of women and hemophilia: a narrative review of evolving beliefs and testing practices‘ article published in the Journal of Thrombosis and Haemostasis sheds light, continued research and advocacy are essential to close these gaps and ensure equitable care for women with hemophilia.
Stay updated on the emerging topics in hematology with Hemostasis Today.
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver